An open-label trial to assess the safety of regorafenib in Turkish patients with metastatic colorectal cancer (mCRC) that progressed on standard therapy (REGARD)

Dane F., Ozgurdal K., Yalcin S., Benekli M., Aykan N. F., Yucel I., ...More

ESMO 17th World Congress on Gastrointestinal Cancer, Barcelona, Spain, 1 - 04 July 2015, vol.26, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 26
• Doi Number: 10.1093/annonc/mdv233.253
• City: Barcelona
• Country: Spain
• Marmara University Affiliated: Yes